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Mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (Mecp2) cause
most cases of Rett syndrome (RTT). Currently there is no cure for RTT. Abnormal EEGs
are found in 100% of RTT cases and are associated with severe sleep dysfunction, the
cause of which is not well understood. Mice deficient in MeCP2 protein have been studied
and characterized for their neuropathological and behavioral deficits to better understand
RTT. With the goal to study the non-ictal EEG correlates in symptomatic Mecp2 KO mice
(Mecp2tm1.1Bird/y), and determine novel EEG biomarkers of their reported progressive
neurodegeneration, we used 24h video-EEG/EMG with synchronous in-vivo cortical
glutamate biosensor in the frontal cortex. We scored the EEG for activity states and
spectral analysis was performed to evaluate correlations to the synchronous extracellular
glutamate fluctuations underlying Mecp2 inactivation as compared to WT. Significant
alterations in sleep structure due to dark cycle-specific long wake states and poor quality
of slow-wave sleep were associated with a significant increase in glutamate loads per
activity cycle. The dynamics of the activity-state-dependent physiological rise and fall
of glutamate indicative of glutamate homeostasis were significantly altered in the KO
mice. Colorimetric quantitation of absolute glutamate levels in frontal cortex also indicated
the presence of significantly higher levels in KO. This study for the first time found
evidence of uncompensated sleep deprivation-like EEG biomarkers that were associated
with glutamate homeostatic dysfunction in the Mecp2 KO mice.
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INTRODUCTION
Rett syndrome (RTT) is an X-linked, neurodevelopmental disor-
der which is a common cause for genetic mental retardation in
girls, one in every 8500 live births. The gene defect in males usu-
ally results in severe clinical manifestations and fatality. Infants
with Rett syndrome seem to grow and develop normally for
6–18 months, but then regress developing and lose skills and
abilities. Autistic-like behaviors also commonly appear at this
stage. Mutations in the gene encoding Mecp2 (methyl-CpG-
binding protein 2) are known to cause the majority of cases
(90–95%, Neul et al., 2008) of typical RTT and are also found
in neuropsychiatric syndromes like autism, bipolar disorder with
Abbreviations: EEG, electroencephalogram; Mecp2, methyl CpG binding protein
2; RTT, Rett syndrome; EMG, electromyogram; REM, rapid eye movement sleep;
NREM, non-rapid eye movement sleep; WT, wild type; KO, knock out.
cognitive deficits and childhood-onset schizophrenia with intel-
lectual disabilities. Currently there is no cure for RTT. Epilepsy
is a major co-morbidity [60–80%, however abnormal EEGs are
found in 100% of RTT cases (Glaze et al., 1998; Hagberg, 2002;
Moser et al., 2007; Glaze et al., 2010; Pintaudi et al., 2010)]. Sleep
dysfunction is commonly reported (Young et al., 2007). However,
little is known about the mechanisms by which chronic sleep dys-
function modulates the severity of temporal deterioration in the
regression stage in RTT. Video-EEG monitoring has been sug-
gested to provide definitive information regarding the need for
therapy in RTT (Glaze et al., 1998).
Mecp2 has many functions and its roles as a transcriptional
repressor, activator, and RNA-binding protein have been exam-
ined. Although the responsible gene was identified more than a
decade ago (Amir et al., 1999), the mechanisms underlying the
RTT symptomatology are poorly understood. Mice with Mecp2
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mutations show neuropathological and behavioral deficits similar
to that reported for RTT (Chen et al., 2001; Guy et al., 2001;
Shahbazian et al., 2002; Chao et al., 2010; De Filippis et al., 2010).
Studies using different strains of Mecp2 mutants have identified
several impairments that likely contribute to the pathophysiology
of the disorder (Shahbazian et al., 2002; Lawson-Yuen et al., 2007;
Jentarra et al., 2010); however the role of Mecp2 inactivation
in sleep and glutamate homeostasis has not been investigated.
Additionally minimal information exists regarding how the loss
of MeCP2 protein affects network activity in the brain (Glaze,
2004). Quantitative EEG (qEEG) with synchronized in-vivo glu-
tamate recordings can provide a valuable tool to evaluate the CNS
network modulation of recently investigated therapeutic inter-
ventions that have shown reversal of respiratory and behavioral
phenotypes (Nag and Berger-Sweeney, 2007; Abdala et al., 2010;
De Filippis et al., 2012).
Due to the high penetrance of MECP2 mutations in humans,
at least some phenotypes that mimic symptoms of human RTT
are common in the male KO Mecp2tm1.1Bird/y mice unlike the
female HET mice that do not become symptomatic until they are
adults. This is reflected in the overall bias of the scientific commu-
nity, which has performed most phenotypic analyses in the male
hemizygous mice. In spite of rigorous neuroanatomical, behav-
ioral, motor and cognitive testing in the mutant males in this
model, no studies have investigated or quantitated their sleep dys-
function (Katz et al., 2012) which is a prominent feature in RTT
patients. In a recent NIHworkshop organized to recognize gaps in
RTT preclinical studies, one of the highlighted goals was to char-
acterize the phenotypes that represent significant challenges for
medical management of individuals with RTT, including seizures,
and gastrointestinal, cardiorespiratory, sensory and sleep-wake
problems (Katz et al., 2012). Sleep dysfunction often occurs in
RTT and is considered a major problem (Young et al., 2007).
High rates of comorbidities of epilepsy and sleep dysfunction with
genetic disorders like RTT, autism, tuberous sclerosis, and frag-
ile X suggest potentially shared underlying mechanisms (Malow,
2004). The precise mechanism by which loss of MeCP2 func-
tion in RTT results in these comorbidities remains uncertain.
Therefore, to investigate the role ofMecp2 X-inactivation on sleep
and glutamate homeostasis, this study, for the first time, used
in-vivo synchronous video-EEG/EMG and glutamate biosensing
(Figure S1A) in symptomatic Mecp2 KO mice. The goal was to
identify definitive quantitative-biomarkers, both in the 24 h EEG
and brain glutamate levels of the KO mice, and investigate their
association with symptomatology during rapid progression of
pathophysiology. This study reports the novel findings of these
experiments.
METHODS
The present study utilized a mouse model of Mecp2 deficiency
developed by Jacky Guy and Adrian Bird (Guy et al., 2001).
Our colony consists of Mecp2tm1.1Bird mice (Jackson Laboratory,
Bar Harbor, Maine) on a C57BL/6 background (heterozygote
backcrossed with C57BL/6 males for at least nine generations).
The Bird Mecp2-deficient mice were bred and housed behind
a barrier in the animal facilities at Johns Hopkins Medical
Institutions with a standard 12-h light on/off cycle with food
and water available ad-libitum. These facilities meet Federal
and NIH regulations for animal care and are accredited by the
American Association for Accreditation of Laboratory Animal
Care. All animal experimentation was conducted in accordance
with protocols approved by the guidelines of the Johns Hopkins
of Animal Care.
For genotyping, tail-clipping samples were obtained between
P4 and P7. The samples were processed using a DNAeasy (Young
et al., 2007) Blood & Tissue Kit from Qiagen for genotyping, as
previously published (Metcalf et al., 2006; Blue et al., 2011)
The Mecp2tm1.1Bird (KO; n = 6) and wild-type mice (WT;
n = 6, 5 males, 1 female, littermates; no male WT littermate was
available for one pair; six paired recordings) used in this study
were all aged between 6–7 weeks. Under general anesthesia, mice
were surgically implanted with electroencephalograph [EEG; sub-
dural electrodes modified from a similar previous protocol used
in rats for chronic EEG recording (Kadam et al., 2010)] and elec-
tromyograph (EMG; supra-scapular) recording electrodes along
with a biosensor guide cannula stereotaxically implanted in the
M1 region of the frontal cortex (A/P + 2.1, M/L+1.0, DV −1.0)
(Figures S1A,B). After recovery from surgery (3–7 days), a gluta-
mate biosensor (Figure S1A) was inserted and glutamate levels
were sampled at 1 s intervals. EEG and EMG waveforms along
with continuous glutamate levels were recorded for an entire 24 h
light-dark cycle.
ELECTRODE CALIBRATION
After recording for 24 h, the glutamate biosensor was explanted
under anesthesia and a post-recording calibration per-
formed according to the manufacturers’ guidelines (Pinnacle
Technologies Inc., Lawrence, KS, USA). Post-calibration glu-
tamate readings (Figure S1C) were used to convert the in-vivo
electrical readout for relative change in glutamate concentrations
inµAMPs into glutamate concentrations in µM (Figure S1C—
inset). Sensitivity of the glutamate biosensor in-situ was tested
by injecting MK801 intra-peritoneal injection (5mg/kg), which
elicited an immediate (<1min) and significant rise in the
glutamate reading, by the sensor (Figure S1D). MK801 which
is an NMDA receptor antagonist is known to induce increases
in endogenous glutamate levels (Wyckhuys et al., 2013) and has
been used tomodel various neurologic disorders, such as epilepsy,
schizophrenia, and Parkinson disease where abnormal glutamate
transmission is hypothesized to be involved (Roenker et al., 2012).
DATA ANALYSIS
EEG and EMG waveforms were recorded and analyzed using the
8400 system recording system and Sirenia sleep software package
(Pinnacle Technology Inc., Lawrence, KS). All recorded wave-
forms were scored as 10 s epochs of WAKE, no-rapid eye move-
ment (NREM) or rapid eye movement (REM) sleep by a blinded
scorer using synchronous EMG and video for confirmation of
wake-inactive states. In 10 s epochs where transitions between
behavioral states occurred, the EEG epoch was scored as the EEG
state that was >5 s (dominant) within that epoch which also cor-
related beautifully with EEG and EEG power for each epoch (see
Figure S2). Glutamate levels were averaged over each 10 s epoch
and correlated with the sleep/wake state after blinded scoring was
complete. Changes in glutamate concentration were calculated
following post-calibration of individual sensors (Figure S1C).
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FIGURE 1 | Blinded video-EEG/EMG manual scoring quantitated activity
cycles to generate (A). Hypnograms for each mouse in the study and showed
significant sleep structure anomalies in the KO mice (B). Histograms
quantitating sleep/wake cycles for the data set (WT and KO n = 6 each)
showed (B1). No significant differences in percent time spent awake or
sleeping were found when light/dark cycles (i.e., 24 h) were pooled together
(lights on 7 am off 7 pm). However, when the data was split by light/dark cycle
(B2,B3). KO mice showed significant sleep deprivation compared to WT mice.
The dark cycle longer wake periods were not associated with any significant
increase in behavioral quantitation for hyperactivity scores. (C) Wake and
sleep cycle quantitation revealed an altered number and duration of cycles
with significantly long wake cycles in KO mice. (C1,C2) Show significantly
lower counts of both wake and sleep cycles in KO mice. (C3,C4) showed that
the wake cycles in KO mice were significantly longer in duration and while the
sleep cycles showed a trend to be longer than in WT mice. (C5) The latency to
first sleep cycle was significantly longer in the KO mice compared to the WTs.
(C6) The duration of the longest wake cycle within each 24 h recording were
significantly longer in KO mice than in WT mice. ∗p < 0.05.
IN-VIVO GLUTAMATE RECORDED TRACE QUANTITATION
Twenty-four hour glutamate recordings showed an initial in-vivo
exponential drop calibration phase of 2–4 h as the recordings
reached a baseline level in each animal. Additionally, during the
24 h continuous recordings some traces showed linear drift con-
tamination of the physiological data. To acquire accurate quan-
titation of glutamate loads for these periods, the data underwent
recalibration for artifact removal. Smoothing splines were applied
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to the calibration period and the follow-on linear drift contami-
nation of the glutamate traces to prevent overestimation of gluta-
mate loads due to drifting baselines. The calibration period, that
began as the biosensor was first inserted in vivo and lasted 2–3 h,
showed sharp drops in the 1st hour. Therefore, the first hour
of readings were not quantitated. Cubic smoothing splines were
applied to readings after 1 h through the end of the calibration
period. The ends of calibration periods for in-vivo stabilization
of readings were selected blinded to EEG/EMG data based on
stable glutamate recordings without an exponential drop. In addi-
tion, linear drift was apparent during certain time periods for
individual traces in the post-calibration period. Time periods for
apparent linear drift in in-vivo glutamate trace recordings were
marked for correction blinded to behavioral states (EEG/EMG).
Again, cubic smoothing splines were applied to drift periods by an
investigator blinded to EEG activity scores. The degree of smooth-
ing was dependent on amount of calibration and drift present
in the glutamate trace irrespective of the associated synchronous
EEG/EMG recording which was reviewed and scored (blinded to
genotype). The mean of the smoothed calibration and drift pieces
were then matched to the mean of the original readings.
AREA UNDER THE CURVE METHOD TO QUANTITATE GLUTAMATE
LOADS PER WAKE CYCLE
The 24 h traces for glutamate recordings were scatter plots of val-
ues recorded per second in real time. Since the in-vivo relative
glutamate concentrations showed ultradian cycling tied to activ-
ity states where peaks matched wake states on EEG and troughs
marked sleep, glutamate loads per wake cycle were calculated as
area between 2 troughs. Automated computations calculated the
area under the curve for each wake cycle. The 2 time points of
the cycle were represented by the 2 lowest points of the sleep cycle
previous to and following a wake cycle. Area under curve was then
calculated using the 1 s trapezoidal rule between those points. All
values reported here were calculated by an automated method
using a code written in R stats (http://www.r-project.org/).
The methods to quantitate REM glutamate loads (area under
the curve) were similar to the overall wake glutamate load cycle
calculations. Using the manually scored EEG for identifying
episodes of REM in both KO andWT, an automated code detected
the lowest points in the EEG synchronous glutamate recording
before and after each REM cycle. Since the REM cycles were short
duration episodes (10’s of seconds) associated with short and
sharp rises in glutamate levels during the trough period, we cal-
culated the area under each REM-cycle-associated glutamate peak
using time points 10 s before and after the start and end of each
REM cycle that was at least ≥30 s long. All values reported here
were calculated by an automated method using a code written in
R stats (http://www.r-project.org/).
PERCENTAGE RATE CHANGE OF GLUTAMATE WITH CHANGE IN
ACTIVITY STATE (SLEEP-WAKE)
In order to calculate the percentage rate of change of glutamate
following wake or sleep, the 1min values after the first 10 s EEG
epoch scored as wake/sleep was averaged to avoid skewed values
due to artifacts. The same was done for another 1min times-
lot recorded 5min later. Once those numbers were calculated, a
simple percentage change, which was the difference in the two
calculated average numbers, divided by the first average was mul-
tiplied by 100 [% rate change GLU = (2nd value–1st value/1st
value)∗100]. The values analyzed here were also generated by an
automated code written in R stats (http://www.r-project.org/).
Percentage rate change of glutamate per REM cycle was calcu-
lated similar to Wake and Sleep. Since the REM cycles last only
for a few epochs of 10 s each, to calculate percent rate of change
of glutamate associated with each REM cycle, we used the average
glutamate values of first 3 s of the first REM epoch in each REM
cycle, then went 5 s further and calculated the average of the 8–
10th seconds of that epoch. The percentage change formula was
then applied to these two values to find the rate change.
IN-VITRO ABSOLUTE BRAIN GLUTAMATE MEASUREMENT
Fresh frozen harvested brain tissue from EEG recorded and
naïve WT and KO mice were resuspended in PBS and soni-
cated briefly, the suspension was then spun at 10,000 rpm for 30 s
and the supernatant collected. Glutamate was measured in a 96-
well microplate with a final volume of 100µl reaction mixture.
Reaction mixture contained 20µl of sample and 70µl comprised
of 50µM Amplex Red (Invitrogen), 0.04U/ml glutamate oxidase
(Sigma), and 0.125U/ml HRP (Sigma), in 100mM Tris–HCl, pH
7.5. Following incubation at 37◦C for 10min, the absorbance
of the reaction mixtures were measured at 560 nm. Background
absorbances were subtracted from each sample, using the sample
incubated with an inactivated enzyme mixture. A standard curve
was constructed ranging from 100 to 3 uM of L-glutamic acid.
Protein concentrations for the brain samples were calculated by
use of the Bradford method with a BSA standard curve.
BEHAVIORAL ACTIVITY SCORING OF SYNCHRONOUS VIDEO
RECORDING
After the 24 h EEG had been scored and wake periods quantified,
the synchronous video was quantitated for behavioral activity for
1 h wake slots both during the light and dark periods. For the
light cycle wake activity on the next morning of 24 h record-
ing were scored to avoid phase of acclimation to the recording
environment. If there were more than one 1 h long wake-cycle,
then 1 h from the longest wake cycle was analyzed using the
highest score detected during 5min blocks of video recorded
behavioral activity. Scores were graded as follows: 1. Inactive-
wake but resting; 2. lightly active-grooming behaviors; 3. medium
active—eating+grooming; 4.active- walking, exploring; and 5.
Hyperactive—running+wet-dog shakes+rearing.
STATISTICS
All quantitative data analyses of glutamate traces was generated
using automated algorithms written in R stats. Effects of light
and dark phases (diurnal) for KO and WT on duration of sleep
state cycles and % rate change were estimated with linear mixed
models with a random mouse effect and interaction of cycle and
type. Independent sample t-tests (Mann-Whitney U) were used
for direct comparisons of quantitative data between the two geno-
types for 24 h glutamate loads and sleep structure data. Sleep cycle
quantitative data was exported from the Sirenia sleep analysis
module after blind scoring of EEG. F-tests were used to compare
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the equality of two variances between group data. For comparing
the correlative strength between two groups, Pearson’s product
moment correlation coefficient, a determiner of linear depen-
dency between two variables, was employed. Significance was set
at p < 0.05. Mean and standard error of the mean are presented
throughout the text and figures.
RESULTS
SLEEP CYCLE DYSFUNCTION
Disrupted sleep-wake cycles have been reported clinically in Rett
syndrome (Ellaway et al., 2001; Young et al., 2007). Similar assess-
ments in Mecp2-deficient mice have been lacking and signifi-
cant alterations have recently been reported for Mecp2-deficient
heterozygous female mice (Wither et al., 2012). In this study,
24 h EEG/EMG recordings analyzed with confirmation from syn-
chronous video recordings revealed significant sleep dysfunction
in Mecp2 KO mice compared to their age-matched WT litter-
mates (Figure 1A). Overall wake and sleep times betweenWT and
KO over 24 h did not show significant differences in wake time
percentages for KO compared to WT (62.2 ± 4.6 vs. 55.2 ± 4.4%,
respectively) and sleep time percentage (37.4 ± 4.6 vs. 44.5 ±
4.6%, respectively; Figure 1B1). The importance of 24 h record-
ing became evident when activity time were spit by light and
dark phase cycles (i.e., bar over Figure 1A hypnograms; 12 h each)
where the data showed a highly significant increase in wake times
for KOmice during the dark cycle (Figures 1B,C) that were absent
during the light cycle.
Rodents cycle between activity states throughout the light and
dark cycle in what is called the ultradian cycle. Since rodents
are nocturnal creatures, they are more active during the dark
cycle than during the light cycle as was evident for WT mice
in Figure 1B. Evaluating the periodic cycling between sleep and
wake cycles in Mecp2 null mice revealed severe disruption of
the normal physiological transition between these activity states.
Overall transitions between wake and sleep cycles were signifi-
cantly lower in KOmice compared toWT (Figures 1C1,C2) when
estimated by total number of wake and sleep cycles for the 24 h
recording. This was a direct result of significantly longer durations
of wake cycles (Figures 1C3,C4). This finding was not significant
for sleep cycles. Since all mice in the study were introduced into
a novel tethered chamber for the recording period, and height-
ened anxiety behavior has been documented in Mecp2 null mice
(Lang et al., 2014); the first wake cycle durations (i.e., latency to
first sleep cycle) were analyzed and found to be longer in KOmice
compared to WT (Figure 1C5), however not significantly (p =
0.06). In contrast, the longest wake cycles during the 24 h period
were typically seen during the dark cycle in KO mice and were
significantly longer than wake cycles inWTmice (Figure 1C6, see
representative KO hypnograms in Figure 1A).
The sleep cycle microstructure in the KO mice also showed
deviations in the number and duration of cycles that was light
cycle-specific (Figure 2A). Severe sleep dysfunction has been
reported in Rett patients (Young et al., 2007). A strong relation-
ship between sleep states, particularly REM sleep and learning,
has previously been reported (Smith, 1996). Sleep microstruc-
ture, as related to NREM and REM cycles, revealed significant
impairments particularly related to the light cycles in KO mice
that were not seen in the WTmice. The 24 h data analysis showed
that the number of NREM and REM cycles (Figures 2B1,B2)
were not significantly different from controls. The average dura-
tions of NREM and REM cycles were also not significantly
different from WT when evaluated over the 24 h recording
period (Figures 2B3,B4). However, these differences became sig-
nificant when looking at longest durations for NREM between
KO mice and WTs (Figure 2B5). Longest duration REM cycles
did not show significant differences between the WT and KOs
(Figure 2B6). More importantly, when the data was analyzed by
light vs. dark cycles, sleep microstructure impairments related
to both the NREM and REM cycle durations became evident.
Significant differences between the light and dark cycle NREM
(p = 0.009) and REM (p = 0.001) cycle durations was detected
in KO mice but not seen in the WTs (Figures 2B7,B8; analy-
ses run using a linear mixed model with random mouse effect).
This shows that, there was a significant diurnal variation in light
and dark cycle NREM and REM durations in the KO mice not
detected in the WT littermate mice, indicating that MeCP2 plays
an important role in maintaining the sleep microstructure.
SLEEP STRUCTURE AND EEG SPECTRAL ANALYSIS
Slow wave-activity (SWA) sleep is characterized by high ampli-
tude low frequency delta wave (0.5–4Hz) predominance espe-
cially during NREM sleep (Figure 3A). REM sleep also known
as pardoxical sleep, lasted a few 10’s of seconds and resembled
wake state EEG in spectral power distribution. However, unlike
wake states, EMG was silent during these episodes. Occasionally
1–2 s short muscle twitches were recorded during REM (see rep-
resentative EMG trace during REM in a WT mouse). Significant
attenuation of delta wave power was noted during NREM sleep in
KOmice compared to the WT (Figures 3A–C). This finding indi-
cates that in addition to the alterations in the sleepmicrostructure
described in Figure 3, the quality of SWA sleep, which is the
hallmark of NREMs, was poor compared to WT littermates.
Therefore, not only was there significant dark cycle sleep depriva-
tion in Mecp2 KO mice, the quality of each sleep cycle was also
severely impaired (Figures 3B,C). This impairment was driven
specifically by significantly low power in the 4Hz frequency SWA
range (Figure 3D) in the KO compared toWT control. This shows
that qEEG identified severe and significant deprivation in SWA as
one of the biomarkers underlying pathogenesis in symptomatic
KO mice.
SLEEP DYSFUNCTION AND LONGWAKE CYCLES WERE NOT
ASSOCIATED WITH A BEHAVIORAL PHENOTYPE
In general, Mecp2 KOmice are universally reported to be hypoac-
tive (Lang et al., 2014). However, none of these reports have
looked at the circadian differences with 24 h recordings since
rodents are more active nocturnally. To ascertain whether the
sleep deprivation ultradian cycles occurring during the dark cycle
with long wake cycles were associated with any behavioral dys-
function, we behaviorally scored every 5min epoch by an activity
scale graded to score increasing activity behaviors on video (see
methods). One hour time slots of video during wake EEGs, both
during the light and dark cycles, were scored every 5min for
the highest activity scores noted based on the scale described
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FIGURE 2 | Sleep microstructure—(A) Representative sleep-wake-cycle
pie charts represent the diurnal variation in wake/sleep cycle (yellow,
red, and blue) changes in WT vs. KO. The pie chart on right (red and blue
only) highlights the sleep pie charts related to NREM vs. REM within the 12 h
activity charts on left. (B) Analysis of sleep microstructure cycles showed
fewer NREM and REM cycles as expected due to fewer ultradian sleep
cycles in KO mice; however this deficit was not significant (B1,B2). In spite of
the lower number of NREM and REM events in KO mice, their duration was
not significantly different from WT mice (B3,B4). To investigate how KO mice
compensated for sleep deprivation, we determined the longest period of
NREM and REM sleep. (B5,B6) KO mice showed a significantly longer
(Continued)
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FIGURE 2 | Continued
duration of the longest NREM than WT mice. However, the duration of the
longest REM cycle was not significantly different in KO and WT mice. (B7,B8)
Bar graphs for mean group data from representative pie charts in (A). KO mice
had a significantly shorter duration of REM sleep cycles during the light cycle
compared to WT mice. Additionally, the average duration of REM sleep cycles
was significantly longer during the dark cycle than during the light cycle in KO
mice that was not detected in WT mice. Average duration of NREMs was not
significantly different between WT and KO however a trend toward diurnal
variation was detected in KO that was not present in WT mice. ∗p < 0.05.
FIGURE 3 | Poor SWA sleep during NREM indicates severe sleep
dysfunction in KO mice. (A) Representative 10 s EEG traces (top panel)
were scored as wake (green), NREM (blue), and REM (red) along with
the synchronous EMG (bottom panel) recorded from WT and KO mice.
Insets on left are spectrograms for the EEG and EMG for those 10 s in
the 0.5–40Hz range (left to right). EEG spectrogram showed that KO
mice had poor power in the delta range (0.5–4Hz) that is typical of SWA
sleep during NREM compared to WT mice. Note WT REM shows a
typical muscle twitch artifact on EMG. (B) Power analyses for the same
mice represented in EEG traces for the 24 h scoring showed a severe
overall deficit in NREM power in delta range in KO mice. EMG power
showed accurate patterns of associations for the EEG scoring in that the
most power was observed during wake states followed by REM when
isolated brief muscle twitches were recorded. Note the artifact peak (∗)
in KO EMG during REM and NREM sleep was due to the leads picking
up EKG signals when the mouse was sleeping in a hunched position. (C)
Group data for quantification of delta power during NREM for each mouse
normalized over delta power during their individual wake cycles showed
significant difference between WT and KO mice in SWA strength. (D)
This significance was driven by delta activity in the 4Hz range.
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in methods. Activity scores (see methods) assigned to video
behaviors during wake cycles did not show significant differences
betweenWT and KOmice. Additionally, the data showed that the
significantly long wake cycles during the dark phase in KO mice
were not associated with any significant hypo- or hyperactivity.
ACTIVITY-DEPENDENT GLUTAMATE LEVELS DISRUPTED IN Mecp2 KO
MICE
Cortical development involves synaptic formation and elimina-
tion. While synaptogenesis predominates earlier and pruning
later, the two processes are thought to happen concurrently
(Maret et al., 2011). The synaptic homeostasis hypothesis of sleep
proposes that slow wave sleep causes downscaling of synaptic
networks potentiated during information uptake in prior wake-
fulness (Born and Feld, 2012). In this study, we found glutamate
peaks associated with wake states, and troughs associated with
sleep, in both the WT and KO mice (Figure 4). Glutamate con-
centrations consistently increased with the onset of wake cycles
and dropped with the onset of sleep. However, the dynamics
of the rate of rise and fall of glutamate were distinctly differ-
ent between the two genotypes (Figure 4A vs. Figure 4B). Unlike
glutamate dynamics detected in WT mice, glutamate levels were
observed to start to drop during the extended wake cycles in the
KO mice (Figure 4A1 vs. Figure 4B1). The sleep cycle and gluta-
mate dynamics were even tighter with miniature short duration
glutamate peaks recorded for every REM cycle (i.e., paradoxical
sleep) within each sleep cycle (Figure 4B1 vs. Figure 4B2).
To calculate glutamate loads associated with each wake cycle
(i.e., area under curve for each wake cycle), every in vivo raw
glutamate trace in the study underwent adjustments for the expo-
nential drop during the in-vivo calibration phase during the initial
2–3 h of recordings and the linear drifts in some traces during
FIGURE 4 | Sleep cycle dysfunction and glutamate loads. (A,B) show
the synchronous and relative glutamate change associated with the
EEG/EMG and video scored hypnograms for representative WT and KO
mice respectively [raw glutamate in-vivo recording (black) overriding
hypnograms (green = wake, blue = NREM, and red = REM) for each
mouse]. Both groups showed an activity dependent increase in glutamate
during the wake cycle and a decrease during the sleep scored EEG.
(A1,B1) Color-coding of the rate of glutamate revealed significant
differences in the dynamics of the rates of change between KO and WT
mice. Scale bar = 1 h. (A2,B2) Expanded times scales of sleep
microstructure [of time slots marked by dotted rectangles in (A1,B1)]
show the slow decline in glutamate levels as sleep progresses and also
the small peaks of glutamate that are tightly correlated with REM cycles
(paradoxical sleep) not clear in the KO.
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the 24 h recording. Automated analysis calculated the area under
each crest associated with each wake cycle. The data demonstrate
that in spite of earlier onset glutamate crest falls associated with
the longer wake cycles in KO mice, the overall mean glutamate
loads associated with wake cycles in KO mice were significantly
larger than those in WT mice [Figure 5A, p< 0.005]. Since some
wake cycles straddled the switch between light to dark cycle and
vice versa, data could not be analyzed for diurnal variation in glu-
tamate loads. However, since activity was consistently associated
with relatively higher glutamate, it was expected that longer wake
cycles associated with the dark cycle would have larger areas under
the curve. There was a highly significant correlation between
glutamate loads and wake durations in both WT and KO mice
[r = 0.65 and 0.75 respectively, and p (2 tailed)< 0.0001 for both
genotypes]. Incomplete wake cycles at the beginning and end of
the recording session were not included in this analysis.
Dynamic and progressive changes in the concentration of glu-
tamate that correlated significantly as a function of behavioral
state as scored on EEG/EMG were noted. These changes were
independent of time of day but dependent on the sleep cycle state.
Therefore, rate of change in glutamate rise and fall as related
to onset of each wake and sleep state were calculated to evalu-
ate glutamate homeostasis associated with the transitional zones
between the wake and sleep states (Figure 5B). Specifically, the
concentration of glutamate increased consistently and progres-
sively on waking (17.03 ± 2.7%/5min) and REM sleep (1.04
± 0.48 %/10 s). This increase was counteracted by a progressive
decrease in relative glutamate levels duringNREM sleep (−8.17 ±
1.42 %/5min) in WT mice. When activity dependent glutamate
homeostasis was evaluated in KO mice, a severe disruption was
noted. Mean percent rate of increase of glutamate with wake was
2.5± 2.4%/5min and significantly slower thanWT (p < 0.0001).
Similarly, mean percent rate of fall of glutamate with sleep onset
was −3.26 ± 1.24%/5min and also significantly slower than WT
(p = 0.02). Comparing glutamate homeostasis within WT mice
for transition to wake vs. sleep states showed the dynamics were
significantly different (p < 0.0001; Figure 6). This difference in
transitional states glutamate homeostasis was completely obliter-
ated in the KO mice (p = 0.1; Figure 6). The restorative function
of sleep has been recently proposed to be a consequence of the
enhanced removal of potentially neurotoxic waste products that
accumulate in the awake central nervous system (Xie et al., 2013).
The significantly slower rate of fall of glutamate with sleep onset
in KO mice supports this hypothesis.
ABSOLUTE BRAIN GLUTAMATE LEVELS ARE HIGHER IN FRONTAL
CORTEX OF KO MICE
Brain glutamate levels measured in frontal cortex of WT and KO
mice at 7 weeks of age (both from recorded and naïve mice) were
significantly higher in KO mice than in WT controls (Figure 7A,
p = 0.008).
CHRONIC SLEEP DEPRIVATION AND DEVELOPMENTAL DEGENERATION
Weights of theWT (male and female), KOmales andHET females
in the breeding colony was recorded over 7 weeks, demonstrated
that HET mice showed no weight lag compared to age-matched
WT females in the period when they are not symptomatic.
However, KO males start to show a weight lag at 3 weeks of
age when compared to WT males that was initially not signifi-
cant but became significant at 7 weeks of age. Twenty-four hour
videos associated with the EEG recording also revealed the same
poor nesting behaviors in symptomatic KOmice compared to the
WT (Figure 7B) that have been previously reported. Mice when
placed in individual recording chambers were provided with a
nest-building material (5 × 5 × 0.5 cm). Every mouse got a new
material pad at the beginning of the 24 h recording, and nesting
ability was scored overnight based on the interaction of individ-
ual mouse with the nesting material on a graded scale previously
described. KO mice scored poorly with nesting since they did
not interact with the material at all, WT mice completely used
the material to build a well-structured nest (p = 0.02), matching
previously reported studies in this mouse model.
FIGURE 5 | (A) Group data for glutamate loads calculated per wake cycle
in drift corrected traces of glutamate in-vivo recordings (see Methods).
Frequency histogram represents glutamate loads per wake (activity) cycle
for every mouse in study and show significantly higher number of
activity cycles with larger glutamate loads in KO mice compared to WT
(red distribution curve shifts to the right, p < 0.03). (B) Frequency
histograms of the percent rates of change of glutamate over time for
every transition to wake and sleep states. Both these transitional
dynamics were significantly altered in KO mice. The KO mice showed a
slower rate of rise (red shift to left) and faster rate of fall (red shift to
right) of glutamate that was associated with transitioning to wake and
sleep respectively, compared to WT mice (black).
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FIGURE 6 | Physiology of sleep and wake state related glutamate
dynamics in WT vs. KO mice. Percent rate of change of glutamate
concentrations in extracellular space following transitions from sleep-wake
to wake-sleep states on EEG, happen within minutes. Percent rate of
change of glutamate over the first 5min of transitioning to a sleep or wake
state for all sleep-wake cycles in the study (n = 103 and 58 WT and KO
respectively) were defined by 2 significantly different and opposite
glutamate dynamics with very little overlap between the 2 transitions
phases in WT mice. This difference was obliterated in KO mice due to
dysfunction of the activity dependent glutamate homeostasis that
distinguished the dynamics between the 2 transition phases and
genotypes at 7 weeks old.
DISCUSSION
This study detected novel EEG and in-vivo glutamate homeostasis
biomarkers that clearly differentiated a symptomatically progres-
sive KO mouse from its age-matched WT littermate. Firstly, we
found that symptomatic KO mice had severe sleep dysfunction
that was circadian- and activity cycle-dependent, and could be
reliably quantitated by the activity state scoring of 24 h con-
tinuous EEGs. The resultant hypnograms represented a chronic
sleep deprivation-like profile that was not followed by compen-
sation. Secondly, the sleep microstructure and quality of SWA
during NREM was also consistently and significantly altered in
the symptomatic KO mice. Impaired NREM and REM dynam-
ics and poor SWA were biomarkers in the symptomatic KO
mice during the progressive deterioration phase that ends in
early mortality in this model. Thirdly, activity-dependent gluta-
mate homeostasis was observed in both WT and KO, but KO
mice showed a significant increase in activity cycle-associated
glutamate loads associated with the long wake cycles. Since these
abnormal activity-dependent glutamate changes were relative to
wake/sleep state and did not represent the actual base load, we
ascertained absolute glutamate concentrations in the frontal cor-
tices. Glutamate levels measured from fresh frozen brain tissue
of recorded and naïve KO mice at 7 weeks of age were signifi-
cantly higher than age-matched WT littermates. Together these
findings suggest that chronically elevated glutamate levels may
underlie the disease progression in this mouse model of Rett
syndrome. Finally, glutamate homeostatic mechanisms associ-
ated with transitions to and from wake and sleep states, were
severely disrupted in the symptomatic KO mice. The percent rate
of rise and fall of glutamate was tightly tied to activity states
as determined by EEG. The dynamics of this change of gluta-
mate concentrations associated with transitions between waking
and sleep states were severely and significantly altered in the KO
brains in-vivo. Specifically, the distinct and significant differences
between the dynamics of the rates of rise of glutamate associated
with wake and rates of fall associated with sleep onset detected in
WT were obliterated in KO mice, which suggested severe homeo-
static dysfunction. In summary, we found a triad of sleep disorder
biomarkers in KO mice that represented both a disintegrated
ultradian rhythm and a dark cycle aggravation that could under-
lie the higher absolute glutamate concentrations detected in the
KO forebrains. Chronic sleep architecture dysfunction and poor
sleep quality in KO mice could be one of the mechanisms under-
lying regression in weight gain, poor nesting and poor learning
memory in these mice (Pelka et al., 2006).
Recent evidence suggests that alterations in cortical gluta-
matergic synaptic responses and excitatory connectivity may play
an important role in RTT, but studies vary in whether the bal-
ance between cortical excitation and inhibition is shifted in favor
of inhibition (Dani et al., 2005) or hyperexcitability (Medrihan
et al., 2008; Zhang et al., 2008). Other studies show that the loss of
Mecp2 function lead to the higher susceptibility of primary neu-
ronal cultures to excitotoxicity (Russell et al., 2007; Fischer et al.,
2009), however these studies were not conducted in the frontal
cortex. The now-established prominent role of glia in RTT patho-
genesis (Maezawa et al., 2009; Maezawa and Jin, 2010; Lioy et al.,
2011) may contribute to excitotoxicity through impaired glu-
tamate re-uptake. The consistent emerging picture with Mecp2
deletion is that there is a regional specificity to the Mecp2 dynam-
ics between glial and neuronal cells that cannot be generalized
for the entire brain (Lioy et al., 2011; Kang et al., 2014). Little
is known as to how synaptic excitability alters as a function of the
clinical stages described in RTT (Glaze and Schultz, 1997). Sleep
cycles are known to play crucial roles in these processes as the
sleep hypnograms evolve in the maturing brain. These secondary
effects, occurring in association with the genetic disruptions of
synaptic plasticity in RTT (also recently shown in a model for
Down’s syndrome; Kaur et al., 2014) may exacerbate the disease
progression and play a significant role in intellectual disabilities.
Therapies directed at correcting these disruptions may provide a
novel mechanism by which to curb disease progression.
In the KO mice, disruption of the ultradian cycle specifically
during the dark cycle denoted by long wake periods represented
a sleep deprivation like profile. As sleep pressure increased, glu-
tamate concentrations ceased to increase and began to decrease
despite continuous waking. In spite of this, glutamate load dur-
ing the wake periods was significantly larger than in WT mice.
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FIGURE 7 | Absolute brain glutamates levels and sleep deprivation a vicious cycle. (A) Brain glutamate levels in frontal cortex were significantly higher in KO
micecompared toWT. (B)Showpoornestingbehaviorscoringasdetected inour24 hvideo recordingswherenestingpadswere leftuntouchedovernight (∗p < 0.05).
In addition, the sleep cycles following the abnormally long wake
cycles did not exhibit the natural compensatory deep sleep home-
ostatic patterns that are known to counteract acute sleep depriva-
tion in WT mice. However, it has been shown that when animals
are chronically sleep deprived compensatory mechanisms begin
to fail even in WT rodents (Kim et al., 2007).
With Mecp2 KOmice, the long wake cycles specific to the dark
phase and the associated higher baseline absolute brain glutamate
levels in the frontal cortex may indicate that the chronic sleep
deprivation like profile of the hypnograms may additionally feed
into the chronic elevation of glutamate levels in the frontal cor-
tices of the symptomatic KO mice. Chronic sleep deprivation can
lead to chronically elevated glutamate levels in the extrasynap-
tic space, which may be one of the reasons of the higher levels
detected in the CSF of RTT patients (Lappalainen and Riikonen,
1996; Horska et al., 2009). The resulting raised glutamate itself
then can act through extrasynaptic glutamate receptors and dis-
rupt brain function and sleep structure (Hardingham and Bading,
2010). This vicious cycle could be one of the mechanisms that
underlie the regressive stages in the lifespan of Mecp2 KO mice.
We also found that the glutamate homeostasis associated with
the wake and sleep states was severely affected in KO mice. These
two findings may underlie a vicious cycle that leads to the early
fatality in KO mice. Activity-dependent neuronal firing patterns,
neuromodulators, and cerebral metabolism modulate the synap-
tic release of glutamate and therefore extrasynaptic glutamate.
Extrasynaptic glutamate in turn can affect neural function and
may be neurotoxic.
Very few studies have investigated how or whether extracellu-
lar glutamate is regulated across sleep-waking states (Dash et al.,
2009). Dash et al. have shown in rats that the progressive increase
in cortical extrasynaptic glutamate during EEG-activated states
(wake) is counteracted by a decrease during NREM sleep that is
additionally modulated by sleep pressure following sleep depri-
vation. Our studies provide evidence for a long-term failure of
homeostasis of extracellular glutamate across sleep-waking states
in KOmice. Disruption of this homeostasis might allow for higher
extrasynaptic glutamate levels over longer periods without com-
pensation that may be toxic over a period of time. However, our
in-vivo investigation was limited to the frontal cortex, and the
findings reported here may depict glutamate-related biomark-
ers specific to that region only. Although in the Mecp2 KO mice
(Mecp2tm1.1Bird/y) examined in this study, the MeCP2 is missing
from the entire brain cell population, there is evidence that it still
results in location- and temporal-specific alterations in synap-
tic physiology (Kang et al., 2014). This may also indicate that
the role of Mecp2 in synaptic physiology in health and disease
is determined by location and age (Lioy et al., 2011).
The EEG pattern of NREM sleep is dominated by SWA. SWA
is defined as the EEG power in the 0.5–4Hz band during NREM
sleep, and is a reliable measure of the amplitude and number
of slow waves during this phase of sleep. SWA is an established
marker of sleep pressure, increasing with the duration of waking
and dissipating throughout sleep. Sleep deprivation studies inWT
rodents and humans have shown a tendency toward NREM com-
pensation by increase in SWA during sleep cycles following sleep
periods of sleep deprivation.With the inherent sleep-deprivation-
like profile detected in all KO hypnograms, not only did the
NREMs following the long wake cycles fail to show any com-
pensatory increase in SWA, in contrast, the poor SWA NREMs
typical to the KO mice persisted following the long wake cycles.
These impairments were statistically significant. Mecp2 KO mice
showed a severe impairment in glutamate homeostasis associ-
ated with SWA during NREM. Glutamate levels decreased at
a faster rate during NREM sleep periods with high SWA than
during those with low SWA. In rats the rate of decrease in glu-
tamate during sleep after sleep deprivation was twice as fast as the
average decrease during spontaneous NREM sleep (Dash et al.,
2009). High sleep pressure seems to enhance the NREM-related
decline in glutamate levels in naïve brains that are sleep deprived.
However, we found that the rate of fall of glutamate duringNREM
following long wake cycles in Mecp2 KOmice was actually slower
than the rate of fall in their age-matched non-sleep deprived
WT littermates. Additionally, although no frank generalized EEG
seizure activity was detected with the 24 h recording protocol in
any of the KO mice, epileptiform spike wave discharges (SWD)
were detected in KOmice, similar to previous reports (Ward et al.,
2011; Lang et al., 2014).
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CONCLUSION
Chronic impairment of sleep and glutamate homeostasis under-
lies the regression in symptomatic Mecp2 KO mice. Continuous
24 h EEG and glutamate recordings allow quantification of
the impairment, which can be used as biomarkers of regres-
sion. Recent work using viral delivery of Mecp2 cDNA has
shown promise by significantly ameliorating the disease in female
mutant mice (Garg et al., 2013) and in male nulls (Gadalla et al.,
2013) based solely on behavioral outcomes. However, the effect
of ectopic transduction of MeCP2 as therapy for the sleep and
glutamate homeostatic markers of disease progression remains
unknown, and future studies could integrate this technology to
investigate the functional rescue of CNS networks. Additionally,
novel intervention therapies can now be tested to evaluate effi-
cacy in rescuing these in-vivo biomarkers to ascertain effect on
modulating regression and preventing fatality.
ACKNOWLEDGMENTS
This research was funded by institute funds from the Hugo W.
Moser Research Institute at Kennedy Krieger, Inc. We thank Dr.
Blue M. E. for graciously providing the genotyped 6 WT and 6
KO mice (Mecp2tm1.1Bird) from the breeding colony maintained
by KKI. We thank Dr. Crainiceanu, C. M. at the Biostatistics
Center at Johns Hopkins Bloomberg School of Public Health for
his invaluable guidance and supervision over the protocols used
for glutamate trace drift correction and automated quantification
using R stats.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://www.frontiersin.org/journal/10.3389/fnsys.2014.
00118/abstract
Figure S1 | Experimental design and biosensor glutamate specificity. (A)
Schematics of biosensor that used glutamate specific oxidative enzyme
reactions to detect every molecule of glutamate in extracellular space
where implanted (image with permission from vendor website). (B)
Schematic of location of stereotaxic implant to biosensor into frontal
neocortex (blue); placement of EEG leads (2 recording and 1 reference)
and mounting screw to anchor head mount to skull. (C) Representative
post-recording calibration trace of recording shows specificity to
glutamate. Step readings for every 10 uM glutamate (three repeats) added
to media were averaged for each sensor in this study (time scale = 1min).
Inset graph shows tight correlation of vendor generated pre-calibration
values for glutamate before implant compared our 24 h post-recording
calibrations. This allowed us to estimate post-calibration values for
biosensors damaged during extraction from brain (red dots). (D) In-vivo
glutamate biosensor recording shows response to an IP injection of
MK801 to a WT mouse in study. Rapid increases in glutamate levels in
trace after injection artifact (arrowhead) indicate potent NMDA receptor
block and sensitivity of biosensor in-vivo (time scale bar = 5min).
Figure S2 | Representative manual EEG scoring for behavioral state
resulting in a 24h hypnogram and the associated automated EEG and
EMG power. (A) shows three traces of EMG power (top black), genotype
blinded and manually scored EEG scoring generated hypnogram (middle)
and automated EEG power (bottom blue) for a single 24 h recording. (A1)
Shows an expanded time scale for duration of recording in (A) marked by
top blue bar. Black arrows show transition states between
wake into sleep and vice-versa that are closely tied to the EMG power
trace that is activity dependent. EEG power in blue shows the opposite
trend to the EMG power trace, with high power during NREM sleep due
to the dominance of high amplitude slow wave-activity (0.5–4Hz SWA)
forms in NREM. The dotted lines highlight the drop in EEG power
associated with onset of every REM cycle within a sleep cycle
(paradoxical sleep). The automated EEG and EMG power alignment to the
manually conducted EEG scoring in this study validates the efficacy of the
behavioral state EEG used to quantitate the sleep architecture.
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